Michelle Surma

920 total citations
12 papers, 735 citations indexed

About

Michelle Surma is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Michelle Surma has authored 12 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Physiology. Recurrent topics in Michelle Surma's work include Protein Kinase Regulation and GTPase Signaling (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers) and Melanoma and MAPK Pathways (3 papers). Michelle Surma is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers) and Melanoma and MAPK Pathways (3 papers). Michelle Surma collaborates with scholars based in United States and China. Michelle Surma's co-authors include Lei Wei, Jianjian Shi, Stephanie Shi, Lumin Zhang, Reuben Kapur, Sasidhar Vemula, Xiangbing Wu, Yang Yu, Jiang Chang and Yang Yang and has published in prestigious journals such as PLoS ONE, The FASEB Journal and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Michelle Surma

11 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle Surma United States 11 427 150 108 102 92 12 735
Federico Corti United States 16 403 0.9× 207 1.4× 78 0.7× 77 0.8× 106 1.2× 24 808
Soumi Kundu United States 17 350 0.8× 161 1.1× 92 0.9× 41 0.4× 111 1.2× 32 803
Xinchun Pi United States 15 578 1.4× 105 0.7× 70 0.6× 142 1.4× 179 1.9× 18 818
Mark V. Stevens United States 12 571 1.3× 147 1.0× 108 1.0× 86 0.8× 103 1.1× 17 866
Nicholas Dean United States 11 682 1.6× 120 0.8× 227 2.1× 70 0.7× 107 1.2× 37 976
Sylvie Rodrigues-Ferreira France 14 445 1.0× 151 1.0× 182 1.7× 105 1.0× 168 1.8× 24 784
Pamela Lockyer United States 17 694 1.6× 158 1.1× 91 0.8× 162 1.6× 86 0.9× 32 1.0k
Mohammad Mahdi Motazacker Netherlands 14 549 1.3× 70 0.5× 99 0.9× 142 1.4× 223 2.4× 18 1.2k
Xianlong Gao United States 18 731 1.7× 158 1.1× 156 1.4× 148 1.5× 87 0.9× 53 1.0k
Antje Augstein Germany 21 426 1.0× 82 0.5× 75 0.7× 175 1.7× 144 1.6× 45 817

Countries citing papers authored by Michelle Surma

Since Specialization
Citations

This map shows the geographic impact of Michelle Surma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Surma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Surma more than expected).

Fields of papers citing papers by Michelle Surma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Surma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Surma. The network helps show where Michelle Surma may publish in the future.

Co-authorship network of co-authors of Michelle Surma

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Surma. A scholar is included among the top collaborators of Michelle Surma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Surma. Michelle Surma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Doud, Emma H., et al.. (2026). Loss of Cathepsin K Impairs Collagen Biogenesis and Enhances Actin Polymerization in Trabecular Meshwork. Investigative Ophthalmology & Visual Science. 67(1). 63–63.
2.
Surma, Michelle, et al.. (2023). Enhanced mitochondrial biogenesis promotes neuroprotection in human pluripotent stem cell derived retinal ganglion cells. Communications Biology. 6(1). 14 indexed citations
3.
Shi, Jianjian, Michelle Surma, Yang Yang, & Lei Wei. (2019). Disruption of both ROCK1 and ROCK2 genes in cardiomyocytes promotes autophagy and reduces cardiac fibrosis during aging. The FASEB Journal. 33(6). 7348–7362. 38 indexed citations
4.
Wei, Lei, Michelle Surma, Yang Yang, Sarah A. Tersey, & Jianjian Shi. (2019). ROCK2 inhibition enhances the thermogenic program in white and brown fat tissue in mice. The FASEB Journal. 34(1). 474–493. 15 indexed citations
5.
Shi, Jianjian, Michelle Surma, & Lei Wei. (2018). Disruption of ROCK1 gene restores autophagic flux and mitigates doxorubicin-induced cardiotoxicity. Oncotarget. 9(16). 12995–13008. 25 indexed citations
6.
Wei, Lei, et al.. (2016). Novel Insights into the Roles of Rho Kinase in Cancer. Archivum Immunologiae et Therapiae Experimentalis. 64(4). 259–278. 156 indexed citations
7.
8.
Surma, Michelle, et al.. (2014). ROCK1 Deficiency Enhances Protective Effects of Antioxidants against Apoptosis and Cell Detachment. PLoS ONE. 9(3). e90758–e90758. 28 indexed citations
9.
Shi, Jianjian, Xiangbing Wu, Michelle Surma, et al.. (2013). Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment. Cell Death and Disease. 4(2). e483–e483. 182 indexed citations
10.
Shi, Jianjian, Michelle Surma, Lumin Zhang, & Lei Wei. (2013). Dissecting the roles of ROCK isoforms in stress-induced cell detachment. Cell Cycle. 12(10). 1492–1500. 30 indexed citations
11.
Shi, Jianjian, et al.. (2012). Downregulation of doxorubicin-induced myocardial apoptosis accompanies postnatal heart maturation. American Journal of Physiology-Heart and Circulatory Physiology. 302(8). H1603–H1613. 31 indexed citations
12.
Surma, Michelle, Lei Wei, & Jianjian Shi. (2011). Rho Kinase As a Therapeutic Target in Cardiovascular Disease. Future Cardiology. 7(5). 657–671. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Federico Corti Breakdown of academic impact, for papers by Soumi Kundu Breakdown of academic impact, for papers by Xinchun Pi Breakdown of academic impact, for papers by Mark V. Stevens Breakdown of academic impact, for papers by Nicholas Dean Breakdown of academic impact, for papers by Sylvie Rodrigues-Ferreira Breakdown of academic impact, for papers by Pamela Lockyer Breakdown of academic impact, for papers by Mohammad Mahdi Motazacker Breakdown of academic impact, for papers by Xianlong Gao Breakdown of academic impact, for papers by Antje Augstein
Rankless by CCL
2026